# Safety and Effectiveness of ELLANSÉ®-S Dermal Filler in the Treatment of Nasolabial Folds

> **NCT06984835** · NA · RECRUITING · sponsor: **AQTIS Medical B.V.** · enrollment: 126 (estimated)

## Conditions studied

- Nasolabial Folds

## Interventions

- **DEVICE:** Ellanse S
- **DEVICE:** Calcium Hydroxylapatite-based filler

## Key facts

- **NCT ID:** NCT06984835
- **Lead sponsor:** AQTIS Medical B.V.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-31
- **Primary completion:** 2026-06
- **Final completion:** 2027-12
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2025-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06984835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06984835, "Safety and Effectiveness of ELLANSÉ®-S Dermal Filler in the Treatment of Nasolabial Folds". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06984835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*